Profile
International Journal of Gastroenterology Disorders & Therapy Volume 1 (2014), Article ID 1:IJGDT-102, 4 pages
http://dx.doi.org/10.15344/2393-8498/2014/102
Review Article
Acute, Chronic and Fulminant Hepatitis E: Ten Years of Experience (2004-2013)

Maria Luisa Mateos Lindemann1, Maria Diez Aguilar1, Ana Gonzalez Galdamez1, Javier Graus Morales2, Ana Moreno Zamora3, Beatriz Suay Garcia4 and Maria Teresa Perez-Gracia4*

1Servicio de Microbiologia. Hospital Universitario Ramon y Cajal. Madrid, Spain
2Servicio de Gastroenterologia. Hospital Universitario Ramon y Cajal. Madrid, Spain
3Servicio de Enfermedades Infecciosas. Hospital Universitario Ramón y Cajal, Madrid, Spain
4Área de Microbiologia. Departamento Farmacia. Instituto Ciencias Biomédicas, Facultad de Ciencias de la Salud. Universidad CEU Cardenal Herrera, Moncada, Valencia, Spain
Dr. Maria Teresa Perez-Gracia, Area de Microbiología. Departamento Farmacia. Instituto Ciencias Biomédicas, Facultad de Ciencias de la Salud. Universidad CEU Cardenal Herrera, Moncada, Valencia, España.; E-mail: teresa@uch.ceu.es
21 May 2014; 05 July 2014; 07 July 2014
Lindemann MLM, Aguilar MD, Galdamez AG, Morales JG, Zamora AM, et al. (2014) Acute, Chronic and Fulminant Hepatitis E: Ten Years of Experience (2004-2013). Int J Gastroenterol Disord Ther 1: 102. doi: http://dx.doi.org/10.15344/2393-8498/2014/102

Abstract

The hepatitis E virus (HEV) is the main cause of acute epidemic hepatitis in developing countries and it is estimated that approximately one third of the world’s population has been infected with this virus. The aim of this study is to describe the most important clinical manifestations and epidemiological aspects in 62 hepatitis E cases treated in Madrid (Spain) during a 10-year period (2004-2013).

Fifty-five patients, six patients and one patient with acute, fulminant and chronic hepatitis E, respectively, have been studied over a period of 10 years. Sixty-two individuals (33 male and 10 female) were treated between 2004 and 2013 in the Hospital Ramón y Cajal (Madrid, Spain). The diagnosis was performed by the detection of IgG and IgM anti-HEV and HEV RNA in serum samples. Acute hepatitis E was defined by the presence of IgM anti-HEV and/or HEV RNA in serum and chronic hepatitis E if the RNA was detectable more than 6 months. Fulminant hepatitis E was diagnosed if encephalopathy was observed in addition to IgM anti-HEV and/or RNA HEV in serum. The median age was 46.67 and 49.6 years in acute hepatitis E and fulminant hepatitis E, respectively. The risk factors recorded were travel to endemic areas in 14 patients, 4 were in contact with animals, 5 suffered from hepatic steatosis due to alcohol consumption, 3 consumed uncontrolled foods and 2 used to drink water from streams. HEV is the cause of acute self-limited hepatitis although 50% of the studied cases had to be hospitalized. However a small number of patients, 4.8% had fulminant hepatitis requiring hepatic transplant. Chronic hepatitis E is very infrequent in immunocompetent individuals. The increase in incidence of hepatitis E is due to better diagnostic tests in these recent years.